Control of type III secretion activity and substrate specificity by the cytoplasmic regulator PcrG.
basic_science · Level V
Where this comes from
- Record sourced from PubMed, PMID 24778208.
- Also identified by DOI 10.1073/pnas.1402658111 and PMC identifier 4024851.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
Pathogenic Gram-negative bacteria use syringe-like type III secretion systems (T3SS) to inject effector proteins directly into targeted host cells. Effector secretion is triggered by host cell contact, and before contact is prevented by a set of conserved regulators. How these regulators interface with the T3SS apparatus to control secretion is unclear. We present evidence that the proton motive force (pmf) drives T3SS secretion in Pseudomonas aeruginosa, and that the cytoplasmic regulator PcrG interacts with distinct components of the T3SS apparatus to control two important aspects of effector secretion: (i) It coassembles with a second regulator (Pcr1) on the inner membrane T3SS component PcrD to prevent effectors from accessing the T3SS, and (ii) In conjunction with PscO, it controls protein secretion activity by modulating the ability of T3SS to convert pmf.
Medical subject headings
- Bacterial Proteins
- Bacterial Secretion Systems
- Pseudomonas aeruginosa